1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00008, MC998C, P30CA015083, CDR0000068503, MAYO-MC998C, NCI-312, NCT00012298
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: UNMC-535-00, NCI-V02-1691, NCT00031642
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2005-002206-37, NCT00302757
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: 98153, P30CA033572, P01CA030206, CHNMC-98153, CDR0000574716, NCT00562978
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02H8, 1346001, NU-0228-024, PCI-P-PCYC-0213, NCT00089284
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04-251, NCT00119730
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: Z-BEAM, NCT00138086
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Ritux plus TNI, NCT00147953
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SCRI LYM 27, 106-P092, NCT00193505
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: No age limit
Sponsor: Other
Protocol IDs: ID03-0287, NCT00290511
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0512, NCT00493467
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1726.00, NCI-2010-01381, FHCRC-1726.00, 5787, NCT00119392
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000334470, ECOG-E1499, E1499, NCT00070447
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000068684, J0004, P30CA006973, JHOC-J0004, NCI-970, J0004, 970, NCT00017381
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI
Protocol IDs: UAB-0127, UAB-F010806018, NCI-G02-2053, NCT00033423
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: COG-ADVL0013, NCT00036855, ADVL0013
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: BMT134, 80109, NCT00186589
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB 7883, CCF IRB 7883, Case 1405, NCT00271050
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 17
Sponsor: NCI, Other
Protocol IDs: NU 99H11, IDEC-NU99H11, NCT00058292
|
Mobile | Español
